<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWire News - Thrombosis via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MedWire News - Thrombosis' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=MedWire+News+-+Thrombosis&t=MedWire+News+-+Thrombosis&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 21 Mar 2010 16:41:27 +0100</lastBuildDate>
        <item>
            <title>Mean platelet volume linked to PE outcome</title>
            <link>http://www.medworm.com/index.php?rid=3384872&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86910%2FThrombosis%2FMean_platelet_volume_linked_to_PE_outcome.html</link>
            <description>Elevated mean platelet volume predicts a poor outcome in patients with pulmonary embolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384872</comments>
            <pubDate>Sat, 20 Mar 2010 15:42:56 +0100</pubDate>
            <guid isPermaLink="false">3384872</guid>        </item>
        <item>
            <title>MM-WES: Genotyping reduces warfarin-associated hospitalizations</title>
            <link>http://www.medworm.com/index.php?rid=3377242&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86862%2FThrombosis%2FMM-WES_Genotyping_reduces_warfarin-associated_hospitalizations.html</link>
            <description>Genotyping patients on warfarin anticoagulation therapy reduces hospitalizations for all causes by nearly 30%, reported investigators from the Medco-Mayo Warfarin Effectiveness Study on the final day of the 59th annual Scientific Sessions of the American College of Cardiology, in Atlanta, Georgia, USA. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3377242</comments>
            <pubDate>Thu, 18 Mar 2010 16:00:18 +0100</pubDate>
            <guid isPermaLink="false">3377242</guid>        </item>
        <item>
            <title>EXPLORE-Xa: Betrixaban bleeding outcomes comparable to warfarin in dose-finding trial</title>
            <link>http://www.medworm.com/index.php?rid=3369279&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86837%2FThrombosis%2FEXPLORE-Xa_Betrixaban_bleeding_outcomes_comparable_to_warfarin_in_dose-finding_trial.html</link>
            <description>The investigational anticoagulant betrixaban has a comparable safety profile to that of warfarin in patients with non-valvular atrial fibrillation or flutter, according to the results of EXPLORE-Xa trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369279</comments>
            <pubDate>Tue, 16 Mar 2010 17:19:54 +0100</pubDate>
            <guid isPermaLink="false">3369279</guid>        </item>
        <item>
            <title>Extended use of dual antiplatet therapy after stent implantation questioned</title>
            <link>http://www.medworm.com/index.php?rid=3369280&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86841%2FThrombosis%2FExtended_use_of_dual_antiplatet_therapy_after_stent_implantation_questioned.html</link>
            <description>Extending the duration of dual antiplatelet therapy for more than 12 months after receipt of drug-eluting stents in patients with no prior bleeding does not appear to be more effective than aspirin monotherapy for reducing the rate of myocardial infarction or cardiovascular death, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369280</comments>
            <pubDate>Tue, 16 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3369280</guid>        </item>
        <item>
            <title>Ticagrelor effective in nonresponders to clopidogrel treatment</title>
            <link>http://www.medworm.com/index.php?rid=3365496&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86817%2FThrombosis%2FTicagrelor_effective_in_nonresponders_to_clopidogrel_treatment_.html</link>
            <description>Coronary artery disease patients who are unresponsive to clopidogrel therapy can reduce their platelet reactivity using ticagrelor, show study findings published in the journal Circulation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365496</comments>
            <pubDate>Mon, 15 Mar 2010 16:08:05 +0100</pubDate>
            <guid isPermaLink="false">3365496</guid>        </item>
        <item>
            <title>PE risk stratification not aided by troponin measurements</title>
            <link>http://www.medworm.com/index.php?rid=3357656&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86790%2FThrombosis%2FPE_risk_stratification_not_aided_by_troponin_measurements.html</link>
            <description>Measuring levels of troponin I does not improve risk assessment using the Pulmonary Embolism Severity Index, study findings show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357656</comments>
            <pubDate>Fri, 12 Mar 2010 15:53:55 +0100</pubDate>
            <guid isPermaLink="false">3357656</guid>        </item>
        <item>
            <title>Optimal anticoagulation unclear for aSTEMI patients with impaired LVEF</title>
            <link>http://www.medworm.com/index.php?rid=3353231&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86774%2FThrombosis%2FOptimal_anticoagulation_unclear_for_aSTEMI_patients_with_impaired_LVEF.html</link>
            <description>Trial findings suggest that triple antiplatelet therapy does not have clear benefits over dual therapy for patients with impaired left ventricular ejection fraction following anterior ST-elevation myocardial infarction. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3353231</comments>
            <pubDate>Thu, 11 Mar 2010 17:20:17 +0100</pubDate>
            <guid isPermaLink="false">3353231</guid>        </item>
        <item>
            <title>Fixed-dose enoxaparin thromboprophylaxis feasible for morbidly obese</title>
            <link>http://www.medworm.com/index.php?rid=3349344&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86737%2FThrombosis%2FFixed-dose_enoxaparin_thromboprophylaxis_feasible_for_morbidly_obese_.html</link>
            <description>US researchers say that enoxaparin administered at a 0.5-mg/kg dose may be effective at preventing thrombosis in morbidly obese patients without increasing the risk for bleeding. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3349344</comments>
            <pubDate>Wed, 10 Mar 2010 17:27:11 +0100</pubDate>
            <guid isPermaLink="false">3349344</guid>        </item>
        <item>
            <title>Screening for asymptomatic thrombophilia reduces provoked VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=3341655&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86717%2FThrombosis%2FScreening_for_asymptomatic_thrombophilia_reduces_provoked_VTE_risk.html</link>
            <description>Screening asymptomatic relatives of patients with hereditary thrombophilias identifies individuals who may benefit from thromboprophylaxis, Dutch researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3341655</comments>
            <pubDate>Mon, 08 Mar 2010 17:08:33 +0100</pubDate>
            <guid isPermaLink="false">3341655</guid>        </item>
        <item>
            <title>Apixaban superior to LMWH for VTE prevention after TKA</title>
            <link>http://www.medworm.com/index.php?rid=3337515&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86701%2FThrombosis%2FApixaban_superior_to_LMWH_for_VTE_prevention_after_TKA.html</link>
            <description>Results from ADVANCE-2 show that the oral active factor Xa inhibitor apixaban offers greater protection from venous thromboembolism following total knee arthroplasty than low molecular weight heparin, without increasing the risk for bleeding. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3337515</comments>
            <pubDate>Sat, 06 Mar 2010 15:43:59 +0100</pubDate>
            <guid isPermaLink="false">3337515</guid>        </item>
        <item>
            <title>VTE patients may not require periprocedural bridging therapy</title>
            <link>http://www.medworm.com/index.php?rid=3334056&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86680%2FThrombosis%2FVTE_patients_may_not_require_periprocedural_bridging_therapy_.html</link>
            <description>Venous thromboembolism patients who have their oral anticoagulation therapy interrupted before an invasive procedure are at low risk for recurrent thrombosis and bleeding, US researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3334056</comments>
            <pubDate>Fri, 05 Mar 2010 15:51:01 +0100</pubDate>
            <guid isPermaLink="false">3334056</guid>        </item>
        <item>
            <title>Proteinuria linked to elevated VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=3325820&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86649%2FThrombosis%2FProteinuria_linked_to_elevated_VTE_risk.html</link>
            <description>In-hospital patients with proteinuria are more than three times as likely to develop venous thromboembolism as those without, US researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325820</comments>
            <pubDate>Wed, 03 Mar 2010 16:02:54 +0100</pubDate>
            <guid isPermaLink="false">3325820</guid>        </item>
        <item>
            <title>Disease-specific questionnaire validated for PE patient QoL</title>
            <link>http://www.medworm.com/index.php?rid=3317680&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86624%2FThrombosis%2FDisease-specific_questionnaire_validated_for_PE_patient_QoL.html</link>
            <description>Dutch researchers have validated the Pulmonary Embolism Quality of Life questionnaire, finding it to give a reliable assessment of patients in the years after an acute episode. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3317680</comments>
            <pubDate>Mon, 01 Mar 2010 16:46:36 +0100</pubDate>
            <guid isPermaLink="false">3317680</guid>        </item>
        <item>
            <title>Warfarin sensitivity falls after valve surgery</title>
            <link>http://www.medworm.com/index.php?rid=3313909&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86604%2FThrombosis%2FWarfarin_sensitivity_falls_after_valve_surgery.html</link>
            <description>Research indicates that a decrease in sensitivity to warfarin in the months after heart valve surgery may place patients at risk for receiving subtherapeutic anticoagulant therapy. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3313909</comments>
            <pubDate>Sat, 27 Feb 2010 15:47:34 +0100</pubDate>
            <guid isPermaLink="false">3313909</guid>        </item>
        <item>
            <title>Clotting factors linked to vascular dementia</title>
            <link>http://www.medworm.com/index.php?rid=3310287&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86588%2FThrombosis%2FClotting_factors_linked_to_vascular_dementia.html</link>
            <description>A long-term prospective study of UK men has shown that hemostatic rather than inflammatory markers predict cognitive impairment and vascular dementia. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3310287</comments>
            <pubDate>Fri, 26 Feb 2010 16:01:41 +0100</pubDate>
            <guid isPermaLink="false">3310287</guid>        </item>
        <item>
            <title>VASP, VerifyNow P2Y12 assays may best reflect clopidogrel responsiveness</title>
            <link>http://www.medworm.com/index.php?rid=3300938&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86561%2FThrombosis%2FVASP%2C_VerifyNow_P2Y12_assays_may_best_reflect_clopidogrel_responsiveness.html</link>
            <description>The flow cytometric vasodilator-stimulated phosphoprotein assay and the VerifyNow P2Y12 assay are the most appropriate platelet function tests to monitor peak plasma levels of the active metabolite of clopidogrel, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3300938</comments>
            <pubDate>Wed, 24 Feb 2010 16:27:18 +0100</pubDate>
            <guid isPermaLink="false">3300938</guid>        </item>
        <item>
            <title>Pre-operative clopidogrel use cautioned for cardiac patients</title>
            <link>http://www.medworm.com/index.php?rid=3293706&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86532%2FThrombosis%2FPre-operative_clopidogrel_use_cautioned_for_cardiac_patients.html</link>
            <description>Study findings highlight the risk for bleeding complications in patients who undergo coronary artery bypass graft surgery within a day of clopidogrel treatment. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3293706</comments>
            <pubDate>Mon, 22 Feb 2010 16:17:25 +0100</pubDate>
            <guid isPermaLink="false">3293706</guid>        </item>
        <item>
            <title>Progestogen type alters VTE risk with hormone therapy</title>
            <link>http://www.medworm.com/index.php?rid=3290141&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86512%2FThrombosis%2FProgestogen_type_alters_VTE_risk_with_hormone_therapy.html</link>
            <description>Route of administration and type of progestogen significantly influence the risk for thrombosis in women using hormone replacement therapy, indicate results from the E3N cohort study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3290141</comments>
            <pubDate>Sat, 20 Feb 2010 15:56:42 +0100</pubDate>
            <guid isPermaLink="false">3290141</guid>        </item>
        <item>
            <title>Oral vitamin K inadequate for pre-op INR correction</title>
            <link>http://www.medworm.com/index.php?rid=3286620&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86496%2FThrombosis%2FOral_vitamin_K_inadequate_for_pre-op_INR_correction_.html</link>
            <description>Oral vitamin K administration does not overcome the requirement for bridging therapy in vitamin K antagonist users who require elective surgery, French researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3286620</comments>
            <pubDate>Fri, 19 Feb 2010 15:50:22 +0100</pubDate>
            <guid isPermaLink="false">3286620</guid>        </item>
        <item>
            <title>SVT linked to increased risk for VTE</title>
            <link>http://www.medworm.com/index.php?rid=3278866&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86461%2FThrombosis%2FSVT_linked_to_increased_risk_for_VTE.html</link>
            <description>Superficial venous thrombosis is not always a benign condition, say French researchers who believe it may herald venous thromboembolism in some patients. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3278866</comments>
            <pubDate>Wed, 17 Feb 2010 16:03:25 +0100</pubDate>
            <guid isPermaLink="false">3278866</guid>        </item>
        <item>
            <title>REACH registry reveals US aspirin use</title>
            <link>http://www.medworm.com/index.php?rid=3272302&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86444%2FThrombosis%2FREACH_registry_reveals_US_aspirin_use.html</link>
            <description>Findings from the REACH Registry reveal that around a quarter of US patients who have atherothrombosis or are at significant risk for the condition are not treated with aspirin and many receive no antithrombotic therapy at all. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3272302</comments>
            <pubDate>Mon, 15 Feb 2010 15:37:33 +0100</pubDate>
            <guid isPermaLink="false">3272302</guid>        </item>
        <item>
            <title>Point-of-care assay allows accurate PCI anticoagulation assessment</title>
            <link>http://www.medworm.com/index.php?rid=3268925&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86433%2FThrombosis%2FPoint-of-care_assay_allows_accurate_PCI_anticoagulation_assessment.html</link>
            <description>A bedside assay allows accurate assessment of enoxaparin anticoagulation in patients undergoing catheterization and percutaneous coronary intervention, French researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3268925</comments>
            <pubDate>Sat, 13 Feb 2010 15:41:11 +0100</pubDate>
            <guid isPermaLink="false">3268925</guid>        </item>
        <item>
            <title>Fondaparinux ACS treatment patterns examined in France</title>
            <link>http://www.medworm.com/index.php?rid=3265872&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86416%2FThrombosis%2FFondaparinux_ACS_treatment_patterns_examined_in_France.html</link>
            <description>Fondaparinux has increasingly been used in French patients with acute coronary syndromes as an alternative to unfractionated heparin or low molecular weight heparin, study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3265872</comments>
            <pubDate>Fri, 12 Feb 2010 15:43:23 +0100</pubDate>
            <guid isPermaLink="false">3265872</guid>        </item>
        <item>
            <title>Low dose rt-PA reduces bleeding risk, retains PTE efficacy</title>
            <link>http://www.medworm.com/index.php?rid=3253510&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86374%2FThrombosis%2FLow_dose_rt-PA_reduces_bleeding_risk%2C_retains_PTE_efficacy.html</link>
            <description>For patients with pulmonary thromboembolism, a 50 mg/2-hour dose of recombinant tissue-type plasminogen activator offers similar benefits to a 100 mg/2-hour dose, but at a significantly reduced risk for bleeding, say Chinese researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3253510</comments>
            <pubDate>Tue, 09 Feb 2010 16:00:24 +0100</pubDate>
            <guid isPermaLink="false">3253510</guid>        </item>
        <item>
            <title>Bridging anticoagulation discrepancies detected among US hospitals</title>
            <link>http://www.medworm.com/index.php?rid=3250202&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86340%2FThrombosis%2FBridging_anticoagulation_discrepancies_detected_among_US_hospitals.html</link>
            <description>Anticoagulation management in patients undergoing surgery varies among hospitals and does not depend solely on patient characteristics, suggest study findings published in the American Journal of Medicine. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3250202</comments>
            <pubDate>Mon, 08 Feb 2010 16:04:12 +0100</pubDate>
            <guid isPermaLink="false">3250202</guid>        </item>
        <item>
            <title>Absolute platelet aggregation unaffected by tapered clopidogrel cessation</title>
            <link>http://www.medworm.com/index.php?rid=3242671&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86333%2FThrombosis%2FAbsolute_platelet_aggregation_unaffected_by_tapered_clopidogrel_cessation.html</link>
            <description>Study findings indicate that tapering the end of clopidogrel therapy does not result in significantly lower absolute platelet aggregation values compared with abrupt termination in patients with drug-eluting stents. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3242671</comments>
            <pubDate>Fri, 05 Feb 2010 16:04:04 +0100</pubDate>
            <guid isPermaLink="false">3242671</guid>        </item>
        <item>
            <title>Single negative compression ultrasound may rule out DVT</title>
            <link>http://www.medworm.com/index.php?rid=3242672&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86316%2FThrombosis%2FSingle_negative_compression_ultrasound_may_rule_out_DVT.html</link>
            <description>A single negative compression ultrasound result may be sufficent for ruling out deep vein thrombosis and withholding anticoagulation therapy in some patients, suggest the results of a meta-analysis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3242672</comments>
            <pubDate>Thu, 04 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3242672</guid>        </item>
        <item>
            <title>CYP2C19-17 linked to elevated clopidogrel bleeding risk</title>
            <link>http://www.medworm.com/index.php?rid=3234601&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86291%2FThrombosis%2FCYP2C19-17_linked_to_elevated_clopidogrel_bleeding_risk.html</link>
            <description>Patients carrying the cytochrome P450 2C19-17 variant have an enhanced response to clopidogrel treatment, increasing their risk for bleeding, caution German researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3234601</comments>
            <pubDate>Wed, 03 Feb 2010 16:06:04 +0100</pubDate>
            <guid isPermaLink="false">3234601</guid>        </item>
        <item>
            <title>Hypocoaguability predicts 30-day ICU survival</title>
            <link>http://www.medworm.com/index.php?rid=3226794&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86261%2FThrombosis%2FHypocoaguability_predicts_30-day_ICU_survival.html</link>
            <description>Intensive care unit patients with hypocoaguability on admission have an increased short-term risk for death, demonstrate the results of a thromboelastography study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3226794</comments>
            <pubDate>Mon, 01 Feb 2010 17:01:33 +0100</pubDate>
            <guid isPermaLink="false">3226794</guid>        </item>
        <item>
            <title>Intravenous opioid users at risk for DVT</title>
            <link>http://www.medworm.com/index.php?rid=3222449&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86252%2FThrombosis%2FIntravenous_opioid_users_at_risk_for_DVT.html</link>
            <description>Intravenous drug use is a significant risk factor for deep vein thrombosis, Iranian researchers suggest after studying a group of opiate addicts. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3222449</comments>
            <pubDate>Sat, 30 Jan 2010 15:51:02 +0100</pubDate>
            <guid isPermaLink="false">3222449</guid>        </item>
        <item>
            <title>Warfarin use in post-ACS AF reduces 6-month mortality, MI</title>
            <link>http://www.medworm.com/index.php?rid=3219356&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86235%2FThrombosis%2FWarfarin_use_in_post-ACS_AF_reduces_6-month_mortality%2C_MI.html</link>
            <description>Warfarin use at discharge from hospital improves short-term outcomes in patients with atrial fibrillation complicated by acute coronary syndromes, suggest study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3219356</comments>
            <pubDate>Fri, 29 Jan 2010 15:38:00 +0100</pubDate>
            <guid isPermaLink="false">3219356</guid>        </item>
        <item>
            <title>Timing of PCI clopidogrel does not affect bleeding outcomes</title>
            <link>http://www.medworm.com/index.php?rid=3211037&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86195%2FThrombosis%2FTiming_of_PCI_clopidogrel_does_not_affect_bleeding_outcomes.html</link>
            <description>Treatment with a high dose of clopidogrel immediately before or after percutaneous coronary intervention results in short-term ischemic outcomes and long-term mortality similar to those of patients who receive clopidogrel according to the current guidelines, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3211037</comments>
            <pubDate>Wed, 27 Jan 2010 15:44:11 +0100</pubDate>
            <guid isPermaLink="false">3211037</guid>        </item>
        <item>
            <title>Fondaparinux anticoagulation less intense, more predictable than enoxaparin</title>
            <link>http://www.medworm.com/index.php?rid=3204093&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86169%2FThrombosis%2FFondaparinux_anticoagulation_less_intense%2C_more_predictable_than_enoxaparin.html</link>
            <description>The less intense and more predictable anticoagulant effect of fondaparinux may explain the drug’s lower rates of bleeding and improved efficacy compared with enoxaparin observed in the Organization to Assess Strategies In acute ischemic Syndromes-5 trial, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3204093</comments>
            <pubDate>Mon, 25 Jan 2010 17:01:27 +0100</pubDate>
            <guid isPermaLink="false">3204093</guid>        </item>
        <item>
            <title>Low FII, FVII and FXI linked to increased CV mortality in the elderly</title>
            <link>http://www.medworm.com/index.php?rid=3196637&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86154%2FThrombosis%2FLow_FII%2C_FVII_and_FXI_linked_to_increased_CV_mortality_in_the_elderly.html</link>
            <description>Low plasma concentrations of coagulation factors II, VII and XI are associated with an increased risk for cardiovascular mortality among elderly people with symptoms of heart failure, Swedish researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3196637</comments>
            <pubDate>Fri, 22 Jan 2010 15:55:47 +0100</pubDate>
            <guid isPermaLink="false">3196637</guid>        </item>
        <item>
            <title>Idiopathic PE linked to poor long-term survival</title>
            <link>http://www.medworm.com/index.php?rid=3196638&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86140%2FThrombosis%2FIdiopathic_PE_linked_to_poor_long-term_survival_.html</link>
            <description>Patients with idiopathic pulmonary embolism have a poorer outcome than patients with a provoked event, study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3196638</comments>
            <pubDate>Thu, 21 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3196638</guid>        </item>
        <item>
            <title>Pre-PCI clopidogrel response testing may reduce major bleeding risk</title>
            <link>http://www.medworm.com/index.php?rid=3188057&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86087%2FThrombosis%2FPre-PCI_clopidogrel_response_testing_may_reduce_major_bleeding_risk.html</link>
            <description>Testing platelet response to clopidogrel before percutaneous coronary intervention could help identify patients at risk for major bleeding, German researchers suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3188057</comments>
            <pubDate>Wed, 20 Jan 2010 16:12:08 +0100</pubDate>
            <guid isPermaLink="false">3188057</guid>        </item>
        <item>
            <title>High risk for recurrent TE in APS patients</title>
            <link>http://www.medworm.com/index.php?rid=3181517&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86062%2FThrombosis%2FHigh_risk_for_recurrent_TE_in_APS_patients.html</link>
            <description>Patients with antiphospholipid syndrome who are triple positive for antiphospholipid antibodies have a high risk for recurrent thromboembolism, Italian researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3181517</comments>
            <pubDate>Mon, 18 Jan 2010 15:41:45 +0100</pubDate>
            <guid isPermaLink="false">3181517</guid>        </item>
        <item>
            <title>Erosion main source of healing thrombi in sudden death patients</title>
            <link>http://www.medworm.com/index.php?rid=3178058&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86045%2FThrombosis%2FErosion_main_source_of_healing_thrombi_in_sudden_death_patients.html</link>
            <description>A study of sudden death patients with acute myocardial infarction suggests that plaque erosions rather than ruptures are the main cause of the healing coronary thrombi, associated with poor outcome in this population. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3178058</comments>
            <pubDate>Sat, 16 Jan 2010 15:31:57 +0100</pubDate>
            <guid isPermaLink="false">3178058</guid>        </item>
        <item>
            <title>Ticagrelor benefits seen in ACS patients undergoing invasive treatment</title>
            <link>http://www.medworm.com/index.php?rid=3174676&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F86031%2FThrombosis%2FTicagrelor_benefits_seen_in_ACS_patients_undergoing_invasive_treatment_.html</link>
            <description>The reversible P2Y12 inhibitor ticagrelor reduces the risk for death and cardiovascular events compared with clopidogrel therapy in patients with acute coronary syndromes, show the results of PLATO-Invasive. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3174676</comments>
            <pubDate>Fri, 15 Jan 2010 15:40:26 +0100</pubDate>
            <guid isPermaLink="false">3174676</guid>        </item>
        <item>
            <title>PESI best predictor for PE outpatient mortality risk</title>
            <link>http://www.medworm.com/index.php?rid=3166133&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85997%2FThrombosis%2FPESI_best_predictor_for_PE_outpatient_mortality_risk.html</link>
            <description>The Pulmonary Embolism Severity Index is more accurate at identifying patients suitable for outpatient treatment than levels of troponin I, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3166133</comments>
            <pubDate>Wed, 13 Jan 2010 15:44:35 +0100</pubDate>
            <guid isPermaLink="false">3166133</guid>        </item>
        <item>
            <title>Hematoma fails to predict PCI outcome</title>
            <link>http://www.medworm.com/index.php?rid=3162805&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85975%2FThrombosis%2FHematoma_fails_to_predict_PCI_outcome.html</link>
            <description>Large hematomas do not significantly predict poor outcomes in patients undergoing percutaneous coronary intervention, indicate results from the STEEPLE trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3162805</comments>
            <pubDate>Tue, 12 Jan 2010 17:06:08 +0100</pubDate>
            <guid isPermaLink="false">3162805</guid>        </item>
        <item>
            <title>Abnormal platelet activation seen in Type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3152286&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85942%2FThrombosis%2FAbnormal_platelet_activation_seen_in_Type_2_diabetes.html</link>
            <description>Type 2 diabetes is associated with upregulation of the platelet-bound CD40/CD40 ligand system, platelet hyperactivity, and increased levels of soluble CD40L, clinical research demonstrates. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3152286</comments>
            <pubDate>Fri, 08 Jan 2010 15:40:23 +0100</pubDate>
            <guid isPermaLink="false">3152286</guid>        </item>
        <item>
            <title>Waist circumference best obesity predictor for VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=3155445&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85955%2FThrombosis%2FWaist_circumference_best_obesity_predictor_for_VTE_risk.html</link>
            <description>Waist circumference is the most accurate measure of obesity for determining risk for venous thromboembolism, Norwegian research indicates. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3155445</comments>
            <pubDate>Fri, 08 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3155445</guid>        </item>
        <item>
            <title>Postoperative VTE risk in women defined</title>
            <link>http://www.medworm.com/index.php?rid=3152287&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85939%2FThrombosis%2FPostoperative_VTE_risk_in_women_defined.html</link>
            <description>The risk for postoperative venous thromboembolism in UK middle-aged women has been clarified using data from the Million Women Study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3152287</comments>
            <pubDate>Thu, 07 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3152287</guid>        </item>
        <item>
            <title>CABG patient risk for pTTP highlighted</title>
            <link>http://www.medworm.com/index.php?rid=3144899&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85900%2FThrombosis%2FCABG_patient_risk_for_pTTP_highlighted.html</link>
            <description>US researchers highlight the importance of early diagnosis of postoperative thrombotic thrombocytopenic purpura in patients after coronary artery bypass graft surgery. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3144899</comments>
            <pubDate>Wed, 06 Jan 2010 15:38:28 +0100</pubDate>
            <guid isPermaLink="false">3144899</guid>        </item>
        <item>
            <title>INR values do not predict thromboembolic events after MVR</title>
            <link>http://www.medworm.com/index.php?rid=3138527&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85875%2FThrombosis%2FINR_values_do_not_predict_thromboembolic_events_after_MVR.html</link>
            <description>Anticoagulation intensity post-mitral valve replacement, although on target as an average, is highly variable and fails to prevent thromboembolic events, a US community-based study has shown. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3138527</comments>
            <pubDate>Mon, 04 Jan 2010 15:37:21 +0100</pubDate>
            <guid isPermaLink="false">3138527</guid>        </item>
        <item>
            <title>Volumetric capnography no better than time-based methods for excluding PE</title>
            <link>http://www.medworm.com/index.php?rid=3117962&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85799%2FThrombosis%2FVolumetric_capnography_no_better_than_time-based_methods_for_excluding_PE.html</link>
            <description>Volume-based capnographic parameters do not appear to improve the performance of the more readily obtained alveolar deadspace fraction for exclusion of suspected pulmonary embolism in outpatients with positive D-dimer test results, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3117962</comments>
            <pubDate>Thu, 24 Dec 2009 15:29:09 +0100</pubDate>
            <guid isPermaLink="false">3117962</guid>        </item>
        <item>
            <title>SPECT scintigraphy feasible alternative to CTPA for PE diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=3110366&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85797%2FThrombosis%2F_SPECT_scintigraphy_feasible_alternative_to_CTPA_for_PE_diagnosis.html</link>
            <description>Single-photon emission computed tomography ventilation/perfusion scintigraphy is a viable alternative to multislice computed tomography pulmonary angiography for the diagnosis of pulmonary embolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3110366</comments>
            <pubDate>Tue, 22 Dec 2009 15:34:50 +0100</pubDate>
            <guid isPermaLink="false">3110366</guid>        </item>
        <item>
            <title>FVIII activity predicts VTE risk in cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=3107871&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85790%2FThrombosis%2FFVIII_activity_predicts_VTE_risk_in_cancer_patients.html</link>
            <description>Measuring factor VIII activity in cancer patients could help determine their risk for venous thromboembolism, suggests research published in the journal Arteriosclersosis, Thrombosis, and Vascular Biology. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3107871</comments>
            <pubDate>Mon, 21 Dec 2009 15:33:41 +0100</pubDate>
            <guid isPermaLink="false">3107871</guid>        </item>
        <item>
            <title>Elinogrel promising adjunct to PCI for STEMI</title>
            <link>http://www.medworm.com/index.php?rid=3099278&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85771%2FThrombosis%2FElinogrel_promising_adjunct_to_PCI_for_STEMI.html</link>
            <description>Results of pilot study show that elinogrel, a novel P2Y12 ADP-receptor antagonist, is a well-tolerated and feasible adjunct antiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3099278</comments>
            <pubDate>Fri, 18 Dec 2009 15:34:43 +0100</pubDate>
            <guid isPermaLink="false">3099278</guid>        </item>
        <item>
            <title>Mean platelet volume may predict VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=3099279&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85788%2FThrombosis%2FMean_platelet_volume_may_predict_VTE_risk.html</link>
            <description>Norwegian researchers have found that a high mean platelet volume increases the risk for venous thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3099279</comments>
            <pubDate>Fri, 18 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3099279</guid>        </item>
        <item>
            <title>Aprotonin benefits outweigh risks for high-risk CPB patients</title>
            <link>http://www.medworm.com/index.php?rid=3095588&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85758%2FThrombosis%2FAprotonin_benefits_outweigh_risks_for_high-risk_CPB_patients.html</link>
            <description>Research shows that for prevention of major blood loss after cardiac surgery, aprotinin has a better risk–benefit profile than tranexamic acid in high-risk, but not low- or moderate-risk cardiopulmonary bypass patients. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3095588</comments>
            <pubDate>Thu, 17 Dec 2009 15:36:20 +0100</pubDate>
            <guid isPermaLink="false">3095588</guid>        </item>
        <item>
            <title>Elinogrel reverses high platelet reactivity in stented patients</title>
            <link>http://www.medworm.com/index.php?rid=3091695&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85737%2FThrombosis%2FElinogrel_reverses_high_platelet_reactivity_in_stented_patients.html</link>
            <description>The direct-acting reversible P2Y12 inhibitor elinogrel is effective in patients who experience high platelet reactivity on conventional dual antiplatelet therapy, report US researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3091695</comments>
            <pubDate>Wed, 16 Dec 2009 15:30:29 +0100</pubDate>
            <guid isPermaLink="false">3091695</guid>        </item>
        <item>
            <title>Diagnostic strategy saves money by ruling out DVT in primary care setting</title>
            <link>http://www.medworm.com/index.php?rid=3088280&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85704%2FThrombosis%2FDiagnostic_strategy_saves_money_by_ruling_out_DVT_in_primary_care_setting.html</link>
            <description>A diagnostic management strategy based on a clinical decision rule and a point of care D-dimer assay is more cost-effective for excluding deep vein thrombosis in primary care patients than hospital-based strategies, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3088280</comments>
            <pubDate>Tue, 15 Dec 2009 15:39:57 +0100</pubDate>
            <guid isPermaLink="false">3088280</guid>        </item>
        <item>
            <title>Clopidogrel-PPI interaction impact on clinical outcomes further explored</title>
            <link>http://www.medworm.com/index.php?rid=3088281&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85711%2FThrombosis%2FClopidogrel-PPI_interaction_impact_on_clinical_outcomes_further_explored.html</link>
            <description>Results of an observational study indicate there is no significant reduction in the clinical efficacy of clopidogrel through concomitant use of a proton-pump inhibitor. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3088281</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3088281</guid>        </item>
        <item>
            <title>Off-licence recombinant activated factor VII guidelines often ignored</title>
            <link>http://www.medworm.com/index.php?rid=3081656&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85669%2FThrombosis%2FOff-licence_recombinant_activated_factor_VII_guidelines_often_ignored.html</link>
            <description>A study of hospitals in Australia and New Zealand has revealed that although most have guidelines for off-license recombinant activated factor VII use, the majority of patients are not treated in accordance with all elements of the guideline. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3081656</comments>
            <pubDate>Sat, 12 Dec 2009 15:23:05 +0100</pubDate>
            <guid isPermaLink="false">3081656</guid>        </item>
        <item>
            <title>Aspirin resistance and elevated MPV linked to poor outcomes in ACS patients</title>
            <link>http://www.medworm.com/index.php?rid=3074322&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85646%2FThrombosis%2FAspirin_resistance_and_elevated_MPV_linked_to_poor_outcomes_in_ACS_patients.html</link>
            <description>Aspirin resistance combined with an elevated mean platelet volume is associated with a poor prognosis in patients with acute coronary syndromes, Turkish researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3074322</comments>
            <pubDate>Thu, 10 Dec 2009 15:27:12 +0100</pubDate>
            <guid isPermaLink="false">3074322</guid>        </item>
        <item>
            <title>Hemostatic markers linked to arterial disease, vascular dementia</title>
            <link>http://www.medworm.com/index.php?rid=3070116&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85620%2FThrombosis%2FHemostatic_markers_linked_to_arterial_disease%2C_vascular_dementia.html</link>
            <description>Elevated D-dimer and fibrinogen are associated with arterial disease in the elderly, report French researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3070116</comments>
            <pubDate>Wed, 09 Dec 2009 15:33:56 +0100</pubDate>
            <guid isPermaLink="false">3070116</guid>        </item>
        <item>
            <title>High BMI predicts failed dose adjustment in patients with HTPR</title>
            <link>http://www.medworm.com/index.php?rid=3066019&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85597%2FThrombosis%2FHigh_BMI_predicts_failed_dose_adjustment_in_patients_with_HTPR.html</link>
            <description>High body mass index, acute coronary syndrome, diabetes mellitus, and the cytochrome P450 2C19*2 polymorphism predict high on-treatment platelet reactivity after treatment with the antiplatelet agent clopidogrel, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3066019</comments>
            <pubDate>Tue, 08 Dec 2009 15:31:01 +0100</pubDate>
            <guid isPermaLink="false">3066019</guid>        </item>
        <item>
            <title>FV Leiden mutation may influence sperm count</title>
            <link>http://www.medworm.com/index.php?rid=3055394&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85562%2FThrombosis%2FFV_Leiden_mutation_may_influence_sperm_count.html</link>
            <description>Sperm count may explain the frequency of the factor V Leiden mutation in White individuals despite its association with pregnancy loss and venous thromboembolism, say Dutch researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3055394</comments>
            <pubDate>Fri, 04 Dec 2009 15:26:27 +0100</pubDate>
            <guid isPermaLink="false">3055394</guid>        </item>
        <item>
            <title>DES thrombosis risk high after clopidogrel withdrawal within 6 months</title>
            <link>http://www.medworm.com/index.php?rid=3055395&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85555%2FThrombosis%2FDES_thrombosis_risk_high_after_clopidogrel_withdrawal_within_6_months.html</link>
            <description>Patients may be at particularly high risk for stent thrombosis if clopidogrel is withdrawn in the first 6 months after receiving a drug-eluting stent, study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3055395</comments>
            <pubDate>Thu, 03 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3055395</guid>        </item>
        <item>
            <title>Rapid and complete CUS feasible and comparable for DVT diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=3043335&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85512%2FThrombosis%2FRapid_and_complete_CUS_feasible_and_comparable_for_DVT_diagnosis.html</link>
            <description>Researchers say that deep venous thrombosis can be efficiently diagnosed using a clinical decision rule, a D-dimer test and a either a rapid or complete compression ultrasound examination. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3043335</comments>
            <pubDate>Tue, 01 Dec 2009 18:08:44 +0100</pubDate>
            <guid isPermaLink="false">3043335</guid>        </item>
        <item>
            <title>Distal DVT mortality risk driven by cancer</title>
            <link>http://www.medworm.com/index.php?rid=3038886&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85478%2FThrombosis%2FDistal_DVT_mortality_risk_driven_by_cancer_.html</link>
            <description>Researchers have identified significant differences in the risk factors and outcomes of patients with distal and proximal deep vein thrombosis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038886</comments>
            <pubDate>Mon, 30 Nov 2009 16:03:59 +0100</pubDate>
            <guid isPermaLink="false">3038886</guid>        </item>
        <item>
            <title>Warfarin linked to valvular calcification in AF patients</title>
            <link>http://www.medworm.com/index.php?rid=3035471&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85471%2FThrombosis%2FWarfarin_linked_to_valvular_calcification_in_AF_patients.html</link>
            <description>Warfarin may increase the risk for valvular calcification in patients with atrial fibrillation, suggests research published in the Journal of Thrombosis and Haemostasis (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3035471</comments>
            <pubDate>Sat, 28 Nov 2009 15:32:42 +0100</pubDate>
            <guid isPermaLink="false">3035471</guid>        </item>
        <item>
            <title>Major bleeding increases mortality risk in hospitalized patients</title>
            <link>http://www.medworm.com/index.php?rid=3028946&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85422%2FThrombosis%2FMajor_bleeding_increases_mortality_risk_in_hospitalized_patients.html</link>
            <description>Major bleeding is a strong predictor of death in hospitalized patients at risk for venous thromboembolism, study results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3028946</comments>
            <pubDate>Thu, 26 Nov 2009 15:48:05 +0100</pubDate>
            <guid isPermaLink="false">3028946</guid>        </item>
        <item>
            <title>High-risk STEMI angioplasty patients benefit from adjunctive GP IIb/IIIa inhibitors</title>
            <link>http://www.medworm.com/index.php?rid=3022013&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85389%2FThrombosis%2FHigh-risk_STEMI_angioplasty_patients_benefit_from_adjunctive_GP_IIbIIIa_inhibitors.html</link>
            <description>High-risk ST elevation myocardial infarction patients undergoing primary angioplasty have a reduced risk for death when given adjunctive glycoprotein IIb/IIIa inhibitor therapy, indicate the results of a meta-analysis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3022013</comments>
            <pubDate>Tue, 24 Nov 2009 16:29:09 +0100</pubDate>
            <guid isPermaLink="false">3022013</guid>        </item>
        <item>
            <title>Cangrelor not CHAMPION for PCI patients</title>
            <link>http://www.medworm.com/index.php?rid=3011255&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85355%2FThrombosis%2FCangrelor_not_CHAMPION_for_PCI_patients.html</link>
            <description>Two CHAMPION trials show disappointing results for the novel fast-acting intravenous platelet inhibitor cangrelor before or after percutaneous coronary intervention, with no reduction in the rate of death, myocardial infarction, or revascularization at 48 hours compared with clopidogrel treatment. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3011255</comments>
            <pubDate>Fri, 20 Nov 2009 15:37:58 +0100</pubDate>
            <guid isPermaLink="false">3011255</guid>        </item>
        <item>
            <title>RE-DEEM: Dabigatran causes no safety concerns in phase II ACS trial</title>
            <link>http://www.medworm.com/index.php?rid=3006996&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85336%2FThrombosis%2FRE-DEEM_Dabigatran_causes_no_safety_concerns_in_phase_II_ACS_trial.html</link>
            <description>When added to dual anti-platelet therapy, the orally administered direct thrombin inhibitor, dabigatran etexilate, results in a “low and acceptable bleeding rate” compared with placebo in patients who have suffered an acute myocardial infarction, according to data presentedat the American Heart Association 2009 Scientific Sessions in, Orlando, Florida, USA. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3006996</comments>
            <pubDate>Thu, 19 Nov 2009 15:44:11 +0100</pubDate>
            <guid isPermaLink="false">3006996</guid>        </item>
        <item>
            <title>HeartMate II: Continuous-flow left ventricular assist device outperforms pulsatile-flow device in advanced heart failure</title>
            <link>http://www.medworm.com/index.php?rid=3006998&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85319%2FThrombosis%2FHeartMate_II_Continuous-flow_left_ventricular_assist_device_outperforms_pulsatile-flow_device_in_advanced_heart_failure.html</link>
            <description>A continuous-flow left ventricular assist device achieved superior outcomes to a pulsatile-flow LVAD in patients with advanced heart failure. In the HeartMate II Destination Therapy clinical trial, 2-year survival for patients implanted with the continuous-flow device was more than double that of patients implanted with the pulsatile-flow device. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3006998</comments>
            <pubDate>Wed, 18 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3006998</guid>        </item>
        <item>
            <title>FAIR-HF: Intravenous iron improves chronic heart failure outcomes</title>
            <link>http://www.medworm.com/index.php?rid=3006997&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85318%2FThrombosis%2FFAIR-HF_Intravenous_iron_improves_chronic_heart_failure_outcomes.html</link>
            <description>Intravenous iron treatment improves multiple clinical outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction, regardless of whether or not they also have anemia, according to data from the FAIR-HF study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3006997</comments>
            <pubDate>Wed, 18 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3006997</guid>        </item>
        <item>
            <title>No improvement in post-op CV events with liberal RBC transfusion strategy</title>
            <link>http://www.medworm.com/index.php?rid=2998515&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85294%2FThrombosis%2FNo_improvement_in_post-op_CV_events_with_liberal_RBC_transfusion_strategy.html</link>
            <description>A liberal strategy of red blood cell transfusion in cases of moderate anemia does not result in better postoperative cardiovascular outcomes compared with a more restrictive strategy of transfusion based primarily on symptomatic anemia in elderly surgical patients, FOCUS trial results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2998515</comments>
            <pubDate>Tue, 17 Nov 2009 15:52:36 +0100</pubDate>
            <guid isPermaLink="false">2998515</guid>        </item>
        <item>
            <title>CASCADE: No added benefit with clopidogrel for saphenous vein grafts after CABG</title>
            <link>http://www.medworm.com/index.php?rid=2998516&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85296%2FThrombosis%2FCASCADE_No_added_benefit_with_clopidogrel_for_saphenous_vein_grafts_after_CABG.html</link>
            <description>The addition of clopidogrel to aspirin failed to significantly reduce intimal hyperplasia in the saphenous vein grafts of patients who underwent coronary artery bypass graft compared with aspirin alone. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2998516</comments>
            <pubDate>Tue, 17 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2998516</guid>        </item>
        <item>
            <title>PLATO: Ticagrelor benefits seen in STEMI subanalysis</title>
            <link>http://www.medworm.com/index.php?rid=2995011&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85271%2FThrombosis%2FPLATO_Ticagrelor_benefits_seen_in_STEMI_subanalysis.html</link>
            <description>The investigational oral antiplatelet therapy ticagrelor significantly reduces the risk for major cardiovascular events and all-cause mortality compared with clopidogrel in patients with ST-segment elevation myocardial infarction and planned primary percutaneous coronary intervention, a predefined subanalysis of the PLATO trial shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2995011</comments>
            <pubDate>Mon, 16 Nov 2009 15:52:06 +0100</pubDate>
            <guid isPermaLink="false">2995011</guid>        </item>
        <item>
            <title>POPULAR defines platelet function assays predictive of clopidogrel outcomes</title>
            <link>http://www.medworm.com/index.php?rid=2998517&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85277%2FThrombosis%2FPOPULAR_defines_platelet_function_assays_predictive_of_clopidogrel_outcomes.html</link>
            <description>Researchers report that three available platelet function assays can identify patients receiving dual antiplatelet therapy who are at increased risk for major cardiovascular events related to poor clopidogrel response. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2998517</comments>
            <pubDate>Mon, 16 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2998517</guid>        </item>
        <item>
            <title>CDT should be ‘first-line treatment’ for acute massive PE</title>
            <link>http://www.medworm.com/index.php?rid=2991930&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85238%2FThrombosis%2FCDT_should_be_%E2%80%98first-line_treatment%E2%80%99_for_acute_massive_PE.html</link>
            <description>Catheter-directed therapy should be the first-line treatment option for patients with acute, massive pulmonary embolism attending hospitals with experienced physicians, US researchers say. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2991930</comments>
            <pubDate>Sat, 14 Nov 2009 15:43:21 +0100</pubDate>
            <guid isPermaLink="false">2991930</guid>        </item>
        <item>
            <title>Pulmonary hypertension more common than thought after submassive PE</title>
            <link>http://www.medworm.com/index.php?rid=2987897&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85228%2FThrombosis%2FPulmonary_hypertension_more_common_than_thought_after_submassive_PE.html</link>
            <description>Signs or symptoms of pulmonary hypertension may be more common after submassive pulmonary embolism than previously thought, US researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2987897</comments>
            <pubDate>Fri, 13 Nov 2009 15:44:12 +0100</pubDate>
            <guid isPermaLink="false">2987897</guid>        </item>
        <item>
            <title>All obesity measures predict VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=2979997&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85196%2FThrombosis%2FAll_obesity_measures_predict_VTE_risk.html</link>
            <description>All measures of obesity predict the risk for venous thrombembolism, not just the most commonly used marker of body mass index, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2979997</comments>
            <pubDate>Wed, 11 Nov 2009 15:49:22 +0100</pubDate>
            <guid isPermaLink="false">2979997</guid>        </item>
        <item>
            <title>Extended PROLONG study follow-up supports continued VKA therapy</title>
            <link>http://www.medworm.com/index.php?rid=2973304&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85168%2FThrombosis%2FExtended_PROLONG_study_follow-up_supports_continued_VKA_therapy.html</link>
            <description>Extended follow-up results of the PROLONG study confirms the benefit of continuing anticoagulation in patients with an elevated D-dimer level 1 month after finishing treatment for idiopathic venous thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2973304</comments>
            <pubDate>Mon, 09 Nov 2009 15:55:09 +0100</pubDate>
            <guid isPermaLink="false">2973304</guid>        </item>
        <item>
            <title>Coagulation markers predict acute MI outcome</title>
            <link>http://www.medworm.com/index.php?rid=2969533&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85140%2FThrombosis%2FCoagulation_markers_predict_acute_MI_outcome.html</link>
            <description>Patients with myocardial infarction have higher levels of key coagulation markers at time of hospital admission than healthy individuals, with the highest levels found in patients with a poor outcome, researchers say. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2969533</comments>
            <pubDate>Sat, 07 Nov 2009 15:24:38 +0100</pubDate>
            <guid isPermaLink="false">2969533</guid>        </item>
        <item>
            <title>D-dimer levels allow short-term PE risk stratification</title>
            <link>http://www.medworm.com/index.php?rid=2966046&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85112%2FThrombosis%2FD-dimer_levels_allow_short-term_PE_risk_stratification.html</link>
            <description>D-dimer levels can help stratify the short-term risk for mortality in patients with pulmonary embolism, Spanish researchers have found. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2966046</comments>
            <pubDate>Fri, 06 Nov 2009 15:29:29 +0100</pubDate>
            <guid isPermaLink="false">2966046</guid>        </item>
        <item>
            <title>Prothrombin fragment F1+2 linked to atherosclerosis development</title>
            <link>http://www.medworm.com/index.php?rid=2957834&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85081%2FThrombosis%2FProthrombin_fragment_F12_linked_to_atherosclerosis_development.html</link>
            <description>Researchers have found a positive association between carotid artery intima media thickness and levels of prothrombin fragment 1+2 in patients with myocardial infarction. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2957834</comments>
            <pubDate>Wed, 04 Nov 2009 16:03:04 +0100</pubDate>
            <guid isPermaLink="false">2957834</guid>        </item>
        <item>
            <title>D-dimer testing valuable in renal dysfunction patients</title>
            <link>http://www.medworm.com/index.php?rid=2949984&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85048%2FThrombosis%2FD-dimer_testing_valuable_in_renal_dysfunction_patients.html</link>
            <description>D-dimer testing is worthwhile in patients with mild or moderately impaired renal function and suspicion of pulmonary embolism, Dutch researchers say, even though the test has a significantly lower specificity than in patients with healthy kidneys. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2949984</comments>
            <pubDate>Mon, 02 Nov 2009 15:51:11 +0100</pubDate>
            <guid isPermaLink="false">2949984</guid>        </item>
        <item>
            <title>LMWH alternative treatment for mechanical valve pregnancy prophylaxis</title>
            <link>http://www.medworm.com/index.php?rid=2942442&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85028%2FThrombosis%2FLMWH_alternative_treatment_for_mechanical_valve_pregnancy_prophylaxis.html</link>
            <description>Low molecular weight heprin is a feasible option for pregnant women with mechanical heart valves who wish to avoid oral anticoagulation therapy, Canadian researchers believe. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2942442</comments>
            <pubDate>Fri, 30 Oct 2009 15:33:06 +0100</pubDate>
            <guid isPermaLink="false">2942442</guid>        </item>
        <item>
            <title>Guidelines on triple therapy use in ACS need expansion</title>
            <link>http://www.medworm.com/index.php?rid=2937772&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F85011%2FThrombosis%2FGuidelines_on_triple_therapy_use_in_ACS_need_expansion.html</link>
            <description>US researchers call for improved guidance on use of anticoagulation and dual antiplatelet agent regimens in patients with acute coronary syndromes. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2937772</comments>
            <pubDate>Thu, 29 Oct 2009 15:34:09 +0100</pubDate>
            <guid isPermaLink="false">2937772</guid>        </item>
        <item>
            <title>F11 SNPs influence DVT risk</title>
            <link>http://www.medworm.com/index.php?rid=2933492&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84992%2FThrombosis%2FF11_SNPs_influence_DVT_risk.html</link>
            <description>Variant forms of the gene encoding factor XI are associated with an increased risk for deep vein thrombosis, shows research published in the Journal of Thormbosis and Haemostasis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2933492</comments>
            <pubDate>Wed, 28 Oct 2009 15:41:44 +0100</pubDate>
            <guid isPermaLink="false">2933492</guid>        </item>
        <item>
            <title>DVT origin of PE questioned in trauma patients</title>
            <link>http://www.medworm.com/index.php?rid=2926565&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84962%2FThrombosis%2FDVT_origin_of_PE_questioned_in_trauma_patients.html</link>
            <description>US researchers have challenged the belief that pulmonary embolism in trauma patients originates from deep vein thrombosis of the pelvis and proximal lower limb blood vessels. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2926565</comments>
            <pubDate>Mon, 26 Oct 2009 16:07:51 +0100</pubDate>
            <guid isPermaLink="false">2926565</guid>        </item>
        <item>
            <title>P2Y12 inhibitor overcomes high platelet reactivity</title>
            <link>http://www.medworm.com/index.php?rid=2922631&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84941%2FThrombosis%2FP2Y12_inhibitor_overcomes_high_platelet_reactivity.html</link>
            <description>A novel direct-acting P2Y12 inhibitor reversibly overcomes high platelet reactivity in patients on clopidogrel and aspirin therapy who have undergone prior coronary stenting, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2922631</comments>
            <pubDate>Sat, 24 Oct 2009 14:18:11 +0100</pubDate>
            <guid isPermaLink="false">2922631</guid>        </item>
        <item>
            <title>Fixed sub-therapeutic dose LMWH ‘feasible’ for bridging anticoagulation</title>
            <link>http://www.medworm.com/index.php?rid=2918988&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84915%2FThrombosis%2FFixed_sub-therapeutic_dose_LMWH_%E2%80%98feasible%E2%80%99_for_bridging_anticoagulation.html</link>
            <description>The use of fixed sub-therapeutic doses of low molecular weight heparin as a bridging regimen in patients on long-term Vitamin-k Antagonist therapy is associated with a low risk for recurrent thrombosis and major bleeding even in high-risk patients, Italian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918988</comments>
            <pubDate>Fri, 23 Oct 2009 14:36:21 +0100</pubDate>
            <guid isPermaLink="false">2918988</guid>        </item>
        <item>
            <title>Age, BMI, and oral contraceptives predict blood clotting factor activity</title>
            <link>http://www.medworm.com/index.php?rid=2907668&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84877%2FThrombosis%2FAge%2C_BMI%2C_and_oral_contraceptives_predict_blood_clotting_factor_activity.html</link>
            <description>Older age and greater body mass index predict the activity of blood clotting factors VIII, FIX, and FXI, while oral contraceptive use predicts FIX, FXI, and FXII activity, report German researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2907668</comments>
            <pubDate>Tue, 20 Oct 2009 14:48:33 +0100</pubDate>
            <guid isPermaLink="false">2907668</guid>        </item>
        <item>
            <title>Age, congenital heart disease influence coagulation tests in children</title>
            <link>http://www.medworm.com/index.php?rid=2907669&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84867%2FThrombosis%2FAge%2C_congenital_heart_disease_influence_coagulation_tests_in_children.html</link>
            <description>Researchers have found that whole blood coagulation tests used for monitoring unfractionated heparin vary with age and presence of congenital heart disease in children. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2907669</comments>
            <pubDate>Mon, 19 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2907669</guid>        </item>
        <item>
            <title>Pharmacist review may boost medical VTE prophylaxis use</title>
            <link>http://www.medworm.com/index.php?rid=2897687&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84834%2FThrombosis%2FPharmacist_review_may_boost_medical_VTE_prophylaxis_use.html</link>
            <description>Pharmacists can improve thromboprophylaxis awareness among physicians treating hospitalized patients, suggest results from a clinical trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2897687</comments>
            <pubDate>Fri, 16 Oct 2009 14:28:45 +0100</pubDate>
            <guid isPermaLink="false">2897687</guid>        </item>
        <item>
            <title>PE risk highlighted in severely ill swine flu patients</title>
            <link>http://www.medworm.com/index.php?rid=2897688&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84822%2FThrombosis%2FPE_risk_highlighted_in_severely_ill_swine_flu_patients.html</link>
            <description>Computed tomography scanning should be performed in patients severely affected by the swine-origin influenza A virus, say US researchers, who found such patients have an increased risk for pulmonary embolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2897688</comments>
            <pubDate>Thu, 15 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2897688</guid>        </item>
        <item>
            <title>Elevated troponin and natriuretic peptides equal poor PE prognosis</title>
            <link>http://www.medworm.com/index.php?rid=2889441&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84796%2FThrombosis%2FElevated_troponin_and_natriuretic_peptides_equal_poor_PE_prognosis.html</link>
            <description>Results from two meta-analyses shed light on the role of troponins in the prognosis of pulmonary embolism, suggesting that elevated levels are most useful for predicting a poor outcome when combined with high concentrations of natriuretic peptide. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2889441</comments>
            <pubDate>Wed, 14 Oct 2009 14:31:50 +0100</pubDate>
            <guid isPermaLink="false">2889441</guid>        </item>
        <item>
            <title>Heparin-induced skin reaction frequency highlighted</title>
            <link>http://www.medworm.com/index.php?rid=2882282&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84770%2FThrombosis%2FHeparin-induced_skin_reaction_frequency_highlighted.html</link>
            <description>Heparin-induced skin lesions are more common than previously thought, report researchers who found the reaction associated with overweight, female gender, and longer duration of heparin therapy. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2882282</comments>
            <pubDate>Mon, 12 Oct 2009 14:28:52 +0100</pubDate>
            <guid isPermaLink="false">2882282</guid>        </item>
        <item>
            <title>Recurrent VTE risk factors do not rule out need for anticoagulation</title>
            <link>http://www.medworm.com/index.php?rid=2878560&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84741%2FThrombosis%2FRecurrent_VTE_risk_factors_do_not_rule_out_need_for_anticoagulation.html</link>
            <description>Study findings show that no single risk factor for recurrent venous thromboembolism is able to guide the use of anticoagulation therapy. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2878560</comments>
            <pubDate>Sat, 10 Oct 2009 18:02:39 +0100</pubDate>
            <guid isPermaLink="false">2878560</guid>        </item>
        <item>
            <title>Early effective anticoagulation required after mitral MHVR</title>
            <link>http://www.medworm.com/index.php?rid=2874725&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84724%2FThrombosis%2FEarly_effective_anticoagulation_required_after_mitral_MHVR.html</link>
            <description>Patients undergoing mitral mechanical heart valve replacement have a high risk for early postoperative thromboembolic events, despite systematic use of intravenous unfractionated heparin, French researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2874725</comments>
            <pubDate>Fri, 09 Oct 2009 10:50:17 +0100</pubDate>
            <guid isPermaLink="false">2874725</guid>        </item>
        <item>
            <title>Pre-hospital high-dose tirofiban reduces early stent thrombosis</title>
            <link>http://www.medworm.com/index.php?rid=2864791&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84693%2FThrombosis%2FPre-hospital_high-dose_tirofiban_reduces_early_stent_thrombosis.html</link>
            <description>Pre-hospital initiation of high-dose tirofiban halves the incidence of early stent thrombosis in patients undergoing primary percutaneous coronary intervention with stenting, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2864791</comments>
            <pubDate>Tue, 06 Oct 2009 18:04:12 +0100</pubDate>
            <guid isPermaLink="false">2864791</guid>        </item>
        <item>
            <title>Risk for frailty predicted by D-dimer and tPA</title>
            <link>http://www.medworm.com/index.php?rid=2861556&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84665%2FThrombosis%2FRisk_for_frailty_predicted_by_D-dimer_and_tPA_.html</link>
            <description>US researchers have found that markers of coagulation and fibrinolysis significantly predict frailty in postmenopausal women. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2861556</comments>
            <pubDate>Mon, 05 Oct 2009 18:09:12 +0100</pubDate>
            <guid isPermaLink="false">2861556</guid>        </item>
        <item>
            <title>LMWH thromboprophylaxis reduces risk for thrombocytopenia</title>
            <link>http://www.medworm.com/index.php?rid=2854394&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84653%2FThrombosis%2FLMWH_thromboprophylaxis_reduces_risk_for_thrombocytopenia.html</link>
            <description>Heparin-associated thrombocytopenia is uncommon after treatment for venous thrombembolism, but the risk could be reduced further by using low molecular weight heparin, researchers suggest in the American Journal of Medicine. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2854394</comments>
            <pubDate>Fri, 02 Oct 2009 18:00:30 +0100</pubDate>
            <guid isPermaLink="false">2854394</guid>        </item>
        <item>
            <title>Medical treatment value questioned for operable CTEPH</title>
            <link>http://www.medworm.com/index.php?rid=2841655&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84604%2FThrombosis%2FMedical_treatment_value_questioned_for_operable_CTEPH.html</link>
            <description>Medical pulmonary hypertensive therapy does not benefit most patients with operable chronic thromboembolic pulmonary hypertension, suggest US researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2841655</comments>
            <pubDate>Tue, 29 Sep 2009 17:57:53 +0100</pubDate>
            <guid isPermaLink="false">2841655</guid>        </item>
        <item>
            <title>Vitamin K diet improves oral anticoagulation control</title>
            <link>http://www.medworm.com/index.php?rid=2838215&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84582%2FThrombosis%2FVitamin_K_diet_improves_oral_anticoagulation_control.html</link>
            <description>Focusing on diet can help patients achieve stable anticoagulation, say Brazilian researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2838215</comments>
            <pubDate>Mon, 28 Sep 2009 17:56:10 +0100</pubDate>
            <guid isPermaLink="false">2838215</guid>        </item>
        <item>
            <title>Fibrinolysis efficacy questioned for left-sided PVT in developing countries</title>
            <link>http://www.medworm.com/index.php?rid=2831053&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84555%2FThrombosis%2FFibrinolysis_efficacy_questioned_for_left-sided_PVT_in_developing_countries.html</link>
            <description>Novel treatments are required for patients with left-sided prosthetic valve thrombosis in developing countries, say clinicians on finding fibrinolysis to be less effective for this indication than previously reported. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2831053</comments>
            <pubDate>Fri, 25 Sep 2009 17:32:52 +0100</pubDate>
            <guid isPermaLink="false">2831053</guid>        </item>
        <item>
            <title>ATTRACT Trial to investigate image-guided DVT treatment</title>
            <link>http://www.medworm.com/index.php?rid=2818204&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84502%2FThrombosis%2FATTRACT_Trial_to_investigate_image-guided_DVT_treatment.html</link>
            <description>Image-guided interventional radiology may play an increasing role in the treatment of deep vein thrombosis, suggests a report in the American Journal of Roentgenology. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2818204</comments>
            <pubDate>Tue, 22 Sep 2009 17:38:05 +0100</pubDate>
            <guid isPermaLink="false">2818204</guid>        </item>
        <item>
            <title>Thrombophilia linked to elevated hemoglobin</title>
            <link>http://www.medworm.com/index.php?rid=2813897&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84477%2FThrombosis%2FThrombophilia_linked_to_elevated_hemoglobin.html</link>
            <description>Young women carrying the factor V Leiden mutation have elevated hemoglobin levels, say Swedish researchers, who believe the mutation could be an evolutionary quirk. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2813897</comments>
            <pubDate>Mon, 21 Sep 2009 17:36:32 +0100</pubDate>
            <guid isPermaLink="false">2813897</guid>        </item>
        <item>
            <title>Fondaparinux plus thrombolysis feasible for PE treatment</title>
            <link>http://www.medworm.com/index.php?rid=2806522&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84469%2FThrombosis%2FFondaparinux_plus_thrombolysis_feasible_for_PE_treatment_.html</link>
            <description>The factor Xa inhibitor fondaparinux can be used alongside thrombolysis to treat pulmonary embolism, suggests preliminary French research. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2806522</comments>
            <pubDate>Fri, 18 Sep 2009 17:26:51 +0100</pubDate>
            <guid isPermaLink="false">2806522</guid>        </item>
        <item>
            <title>SVG occlusion independent of HIT antibodies</title>
            <link>http://www.medworm.com/index.php?rid=2795622&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84409%2FThrombosis%2FSVG_occlusion_independent_of_HIT_antibodies_.html</link>
            <description>US research indicates that the antibodies that cause heparin-induced thrombocytopenia do not increase the risk for early saphenous vein graft occlusion in patients undergoing coronary artery bypass graft surgery. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2795622</comments>
            <pubDate>Tue, 15 Sep 2009 17:38:58 +0100</pubDate>
            <guid isPermaLink="false">2795622</guid>        </item>
        <item>
            <title>Variant alleles confer increased risk for VTE in elderly</title>
            <link>http://www.medworm.com/index.php?rid=2792422&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84388%2FThrombosis%2FVariant_alleles_confer_increased_risk_for_VTE_in_elderly_.html</link>
            <description>Variants coagulation genes may contribute to the increased risk for venous thromboembolism found in older individuals, US researchers suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2792422</comments>
            <pubDate>Mon, 14 Sep 2009 17:33:52 +0100</pubDate>
            <guid isPermaLink="false">2792422</guid>        </item>
        <item>
            <title>Dual antiplatelet therapy best for low TE risk patients after stenting</title>
            <link>http://www.medworm.com/index.php?rid=2784924&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84367%2FThrombosis%2FDual_antiplatelet_therapy_best_for_low_TE_risk_patients_after_stenting.html</link>
            <description>Oral anticoagulant therapy regimens in percutaneous coronary intervention and stent implantation patients should be tailored to their risk for thromboembolism, researchers suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2784924</comments>
            <pubDate>Fri, 11 Sep 2009 17:37:41 +0100</pubDate>
            <guid isPermaLink="false">2784924</guid>        </item>
        <item>
            <title>rFVIIa reduces postoperative bleeding</title>
            <link>http://www.medworm.com/index.php?rid=2781005&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84336%2FThrombosis%2FrFVIIa_reduces_postoperative_bleeding.html</link>
            <description>Recombinant activated factor VII may reduce bleeding after cardiac surgery, suggest study findings published in the journal Circulation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2781005</comments>
            <pubDate>Thu, 10 Sep 2009 17:33:49 +0100</pubDate>
            <guid isPermaLink="false">2781005</guid>        </item>
        <item>
            <title>VTE risk independent of diabetes diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=2773971&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84322%2FThrombosis%2FVTE_risk_independent_of_diabetes_diagnosis.html</link>
            <description>The risk for venous thromboembolism is not elevated by diabetes or related conditions, US research indicates. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2773971</comments>
            <pubDate>Tue, 08 Sep 2009 17:43:39 +0100</pubDate>
            <guid isPermaLink="false">2773971</guid>        </item>
        <item>
            <title>Proximal and distal DVT patients differ in mortality risk</title>
            <link>http://www.medworm.com/index.php?rid=2771735&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84288%2FThrombosis%2FProximal_and_distal_DVT_patients_differ_in_mortality_risk.html</link>
            <description>Patients with proximal deep vein thrombosis have a higher risk for death than those with distal clots, show results from the OPTIMEV study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2771735</comments>
            <pubDate>Mon, 07 Sep 2009 17:29:01 +0100</pubDate>
            <guid isPermaLink="false">2771735</guid>        </item>
        <item>
            <title>TEG results affected by blood acidosis, low temp</title>
            <link>http://www.medworm.com/index.php?rid=2769992&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84271%2FThrombosis%2FTEG_results_affected_by_blood_acidosis%2C_low_temp.html</link>
            <description>Hemostasis testing should take into account patient physiologic factors, say scientists who found that thromboelastography results are affected by blood pH and temperature. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2769992</comments>
            <pubDate>Sun, 06 Sep 2009 17:29:56 +0100</pubDate>
            <guid isPermaLink="false">2769992</guid>        </item>
        <item>
            <title>Biomarkers predict VTE risk in cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=2760921&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84235%2FThrombosis%2FBiomarkers_predict_VTE_risk_in_cancer_patients_.html</link>
            <description>The Vienna Cancer and Thrombosis study shows that venous thromboembolism can be predicted in cancer patients using levels of D-dimer and prothrombin fragment 1+2. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2760921</comments>
            <pubDate>Thu, 03 Sep 2009 17:31:59 +0100</pubDate>
            <guid isPermaLink="false">2760921</guid>        </item>
        <item>
            <title>AAA study finds no benefit of aspirin in asymptomatic atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2750801&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84167%2FThrombosis%2FAAA_study_finds_no_benefit_of_aspirin_in_asymptomatic_atherosclerosis_.html</link>
            <description>Chronic use of low-dose aspirin does not prevent vascular events in people with asymptomatic atherosclerotic disease detected using the ankle brachial index, study findings show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2750801</comments>
            <pubDate>Tue, 01 Sep 2009 13:11:39 +0100</pubDate>
            <guid isPermaLink="false">2750801</guid>        </item>
        <item>
            <title>proCPU levels alter thrombosis risk in thrombophilic patients</title>
            <link>http://www.medworm.com/index.php?rid=2756030&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84188%2FThrombosis%2FproCPU_levels_alter_thrombosis_risk_in_thrombophilic_patients.html</link>
            <description>A variant gene that increases levels of procarboxypeptidase U raises the risk for thrombosis in thrombophilic patients, suggests study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2756030</comments>
            <pubDate>Tue, 01 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2756030</guid>        </item>
        <item>
            <title>RE-LY: Dabigatran lowers stroke risk versus warfarin in AF patients</title>
            <link>http://www.medworm.com/index.php?rid=2750804&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84170%2FThrombosis%2FRE-LY_Dabigatran_lowers_stroke_risk_versus_warfarin_in_AF_patients.html</link>
            <description>Treatment with dabigatran significantly reduces stroke risk in comparison with warfarin in patients with atrial fibrillation and at least one risk factor, results of the Randomized Evaluation of Long-term anticoagulant therapY trial show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2750804</comments>
            <pubDate>Tue, 01 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2750804</guid>        </item>
        <item>
            <title>PLATO: Ticagrelor beats clopidogrel in ACS</title>
            <link>http://www.medworm.com/index.php?rid=2750803&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84169%2FThrombosis%2FPLATO_Ticagrelor_beats_clopidogrel_in_ACS.html</link>
            <description>The novel antiplatelet therapy ticagrelor reduces the rate of cardiovascular events and death compared with clopidogrel treatment in patients with acute coronary syndrome, without any increase in major bleeding events, the PLATO trial results indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2750803</comments>
            <pubDate>Tue, 01 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2750803</guid>        </item>
        <item>
            <title>CURRENT OASIS-7: Doubling clopidogrel dosing has ‘favorable net clinical benefit’</title>
            <link>http://www.medworm.com/index.php?rid=2750802&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84168%2FThrombosis%2FCURRENT_OASIS-7_Doubling_clopidogrel_dosing_has_%E2%80%98favorable_net_clinical_benefit%E2%80%99_.html</link>
            <description>Doubling the loading and maintenance doses of clopidogrel in the week before percutaneous coronary intervention significantly improves outcomes in patients with acute coronary syndromes, data from the large-scale CURRENT OASIS-7 study show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2750802</comments>
            <pubDate>Tue, 01 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2750802</guid>        </item>
        <item>
            <title>CTPA rules out PE in high-risk patients</title>
            <link>http://www.medworm.com/index.php?rid=2743246&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84148%2FThrombosis%2FCTPA_rules_out_PE_in_high-risk_patients.html</link>
            <description>Computed tomography pulmonary angiography can rule out pulmonary embolism in patients with a high pretest probability of thrombosis and/or positive D-dimer test, show the results of a meta-analysis published in the Journal of Thrombosis and Haemostasis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2743246</comments>
            <pubDate>Sat, 29 Aug 2009 12:57:24 +0100</pubDate>
            <guid isPermaLink="false">2743246</guid>        </item>
        <item>
            <title>10-mg warfarin nomogram effective in ‘real life’ practice</title>
            <link>http://www.medworm.com/index.php?rid=2740377&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84126%2FThrombosis%2F10-mg_warfarin_nomogram_effective_in_%E2%80%98real_life%E2%80%99_practice.html</link>
            <description>Results from a “real life” study support the use of a 10-mg warfarin initiation nomogram in outpatients requiring oral anticoagulation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2740377</comments>
            <pubDate>Fri, 28 Aug 2009 12:59:39 +0100</pubDate>
            <guid isPermaLink="false">2740377</guid>        </item>
        <item>
            <title>Deoxygenated hemoglobin levels predict PTS</title>
            <link>http://www.medworm.com/index.php?rid=2733122&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84088%2FThrombosis%2FDeoxygenated_hemoglobin_levels_predict_PTS.html</link>
            <description>Research suggests that measuring deoxygenated hemoglobin levels in calf muscle may help identify deep vein thrombosis patients at greatest risk for post-thrombotic syndrome. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2733122</comments>
            <pubDate>Wed, 26 Aug 2009 13:07:29 +0100</pubDate>
            <guid isPermaLink="false">2733122</guid>        </item>
        <item>
            <title>CFX–INR relationship changes over warfarin treatment</title>
            <link>http://www.medworm.com/index.php?rid=2726677&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84064%2FThrombosis%2FCFX%E2%80%93INR_relationship_changes_over_warfarin_treatment.html</link>
            <description>The relationship between the chromogenic factor X assay and international normalized ratio changes over time in patients receiving warfarin treatment, US study findings show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2726677</comments>
            <pubDate>Mon, 24 Aug 2009 13:10:39 +0100</pubDate>
            <guid isPermaLink="false">2726677</guid>        </item>
        <item>
            <title>Point-of-care D-dimer testing excludes VTE in low-risk patients</title>
            <link>http://www.medworm.com/index.php?rid=2722630&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84036%2FThrombosis%2FPoint-of-care_D-dimer_testing_excludes_VTE_in_low-risk_patients.html</link>
            <description>Point-of-care D-dimer tests can rule out venous thromboembolism in outpatients with a low pre-test probability for thrombosis, indicate the results of a meta-analysis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2722630</comments>
            <pubDate>Sat, 22 Aug 2009 11:16:59 +0100</pubDate>
            <guid isPermaLink="false">2722630</guid>        </item>
        <item>
            <title>Pulmonary CTA useful for pediatric patients with suspicion of PE</title>
            <link>http://www.medworm.com/index.php?rid=2718733&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F84021%2FThrombosis%2FPulmonary_CTA_useful_for_pediatric_patients_with_suspicion_of_PE.html</link>
            <description>Study findings demonstrate the usefulness of pulmonary computed tomography angiography in children with suspected pulmonary embolism, even when venous thromboembolism is ruled out. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2718733</comments>
            <pubDate>Fri, 21 Aug 2009 11:17:47 +0100</pubDate>
            <guid isPermaLink="false">2718733</guid>        </item>
        <item>
            <title>Computer program identifies patients at HIT risk</title>
            <link>http://www.medworm.com/index.php?rid=2711175&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83990%2FThrombosis%2FComputer_program_identifies_patients_at_HIT_risk.html</link>
            <description>A computerized system can alert physicians to patients at risk for heparin-induced thrombocytopenia based on subtle platelet count changes, say US researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2711175</comments>
            <pubDate>Wed, 19 Aug 2009 11:17:55 +0100</pubDate>
            <guid isPermaLink="false">2711175</guid>        </item>
        <item>
            <title>Small increased bleeding risk for anticoagulated cataract patients</title>
            <link>http://www.medworm.com/index.php?rid=2707946&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83970%2FThrombosis%2FSmall_increased_bleeding_risk_for_anticoagulated_cataract_patients.html</link>
            <description>Continuing warfarin treatment in patients undergoing cataract surgery presents a small increase in risk for bleeding, study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2707946</comments>
            <pubDate>Tue, 18 Aug 2009 11:21:48 +0100</pubDate>
            <guid isPermaLink="false">2707946</guid>        </item>
        <item>
            <title>VTE risk varies with OC progestogen, estrogen content</title>
            <link>http://www.medworm.com/index.php?rid=2701483&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83940%2FThrombosis%2FVTE_risk_varies_with_OC_progestogen%2C_estrogen_content.html</link>
            <description>The risk for venous thromboembolism in women using oral contraceptives varies with type of progestogen and estrogen dose, demonstrate results from two studies published in the BMJ. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2701483</comments>
            <pubDate>Sat, 15 Aug 2009 11:13:30 +0100</pubDate>
            <guid isPermaLink="false">2701483</guid>        </item>
        <item>
            <title>Thrombectomy plus thrombolysis effective for massive DVT</title>
            <link>http://www.medworm.com/index.php?rid=2698386&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83926%2FThrombosis%2FThrombectomy_plus_thrombolysis_effective_for_massive_DVT.html</link>
            <description>Percutaneous mechanical thromboectomy with catheter-direct thrombolysis is feasible for the treatment of patients with massive symptomatic lower limb deep vein thrombosis, say Chinese researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2698386</comments>
            <pubDate>Fri, 14 Aug 2009 11:20:22 +0100</pubDate>
            <guid isPermaLink="false">2698386</guid>        </item>
        <item>
            <title>Specific FXa inhibition thromboprophylaxis ‘acceptable to clinicians’</title>
            <link>http://www.medworm.com/index.php?rid=2690579&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83897%2FThrombosis%2FSpecific_FXa_inhibition_thromboprophylaxis_%E2%80%98acceptable_to_clinicians%E2%80%99.html</link>
            <description>The specific factor Xa inhibitor apixaban may be suitable thromboprophylaxis for patients undergoing major joint replacement surgery, researchers suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2690579</comments>
            <pubDate>Wed, 12 Aug 2009 11:35:12 +0100</pubDate>
            <guid isPermaLink="false">2690579</guid>        </item>
        <item>
            <title>Genetics has broad impact on VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=2687368&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83870%2FThrombosis%2FGenetics_has_broad_impact_on_VTE_risk.html</link>
            <description>Findings from a meta-analysis demonstrate the impact of genetics on the development of venous thromboembolism in patients of different ethnicities. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687368</comments>
            <pubDate>Tue, 11 Aug 2009 11:41:20 +0100</pubDate>
            <guid isPermaLink="false">2687368</guid>        </item>
        <item>
            <title>LMWH home therapy feasible for DVT</title>
            <link>http://www.medworm.com/index.php?rid=2680947&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83839%2FThrombosis%2FLMWH_home_therapy_feasible_for_DVT_.html</link>
            <description>Patients with acute proximal deep vein thrombosis can be successfully treated using low molecular weight heparin at home from the outset, indicate results from the Home-LITE trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2680947</comments>
            <pubDate>Sat, 08 Aug 2009 11:51:35 +0100</pubDate>
            <guid isPermaLink="false">2680947</guid>        </item>
        <item>
            <title>LEFt variables predict DVT in pregnant women</title>
            <link>http://www.medworm.com/index.php?rid=2677713&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83827%2FThrombosis%2FLEFt_variables_predict_DVT_in_pregnant_women.html</link>
            <description>Canadian researchers have devised a pretest probability assessment that may be able to rule out deep vein thrombosis in pregnancy. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2677713</comments>
            <pubDate>Fri, 07 Aug 2009 11:56:36 +0100</pubDate>
            <guid isPermaLink="false">2677713</guid>        </item>
        <item>
            <title>UFH stacked-on to enoxaparin ‘should be avoided’</title>
            <link>http://www.medworm.com/index.php?rid=2669927&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83795%2FThrombosis%2FUFH_stacked-on_to_enoxaparin_%E2%80%98should_be_avoided%E2%80%99.html</link>
            <description>Administration of an additional intravenous unfractionated heparin bolus to individuals already receiving standard enoxaparin therapy results in complete inhibition of thrombin generation, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2669927</comments>
            <pubDate>Wed, 05 Aug 2009 11:55:52 +0100</pubDate>
            <guid isPermaLink="false">2669927</guid>        </item>
        <item>
            <title>Novel warfarin dosing equation developed</title>
            <link>http://www.medworm.com/index.php?rid=2666351&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83770%2FThrombosis%2FNovel_warfarin_dosing_equation_developed.html</link>
            <description>Canadian researchers have developed a group of equations based on readily available information that predicts maintenance warfarin dose in outpatients with venous thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2666351</comments>
            <pubDate>Tue, 04 Aug 2009 12:03:15 +0100</pubDate>
            <guid isPermaLink="false">2666351</guid>        </item>
        <item>
            <title>Post-PCI bleeding increased in triple therapy patients</title>
            <link>http://www.medworm.com/index.php?rid=2659846&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83747%2FThrombosis%2FPost-PCI_bleeding_increased_in_triple_therapy_patients.html</link>
            <description>Adding dual antiplatelet therapy to pre-existing oral anticoagulant therapy increases bleeding after percutaneous coronary intervention, French study results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659846</comments>
            <pubDate>Sat, 01 Aug 2009 11:51:03 +0100</pubDate>
            <guid isPermaLink="false">2659846</guid>        </item>
        <item>
            <title>Smoking is an independent risk factor for VTE</title>
            <link>http://www.medworm.com/index.php?rid=2656384&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83719%2FThrombosis%2FSmoking_is_an_independent_risk_factor_for_VTE.html</link>
            <description>Smoking is an independent risk factor for venous thromboembolism among middle-aged men and women, show results of a large prospective study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2656384</comments>
            <pubDate>Fri, 31 Jul 2009 11:53:15 +0100</pubDate>
            <guid isPermaLink="false">2656384</guid>        </item>
        <item>
            <title>Catheter-directed thrombolysis improves DVT vein patency</title>
            <link>http://www.medworm.com/index.php?rid=2647971&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83684%2FThrombosis%2FCatheter-directed_thrombolysis_improves_DVT_vein_patency.html</link>
            <description>Early findings support the use of catheter-directed thrombolysis for the treatment of acute proximal deep vein thrombosis and prevention of post-thrombotic syndrome. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2647971</comments>
            <pubDate>Wed, 29 Jul 2009 11:56:58 +0100</pubDate>
            <guid isPermaLink="false">2647971</guid>        </item>
        <item>
            <title>FV Leiden increases cardiac surgery VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=2641054&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83662%2FThrombosis%2FFV_Leiden_increases_cardiac_surgery_VTE_risk.html</link>
            <description>Patients with inherited thrombophilia from the factor V Leiden mutation have an increased risk for thromboembolism during and after undergoing cardiac surgery, German clinicians warn. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2641054</comments>
            <pubDate>Mon, 27 Jul 2009 11:57:18 +0100</pubDate>
            <guid isPermaLink="false">2641054</guid>        </item>
        <item>
            <title>Rituximab shows TTP efficacy</title>
            <link>http://www.medworm.com/index.php?rid=2637082&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83639%2FThrombosis%2FRituximab_shows_TTP_efficacy.html</link>
            <description>Patients with idiopathic thrombotic thrombocytopenic purpura may benefit from immunosuppressive treatment with the therapeutic monoclonal antibody rituximab, US clinicians believe. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2637082</comments>
            <pubDate>Sat, 25 Jul 2009 11:48:02 +0100</pubDate>
            <guid isPermaLink="false">2637082</guid>        </item>
        <item>
            <title>LMWH effective for pregnancy mechanical heart valve thromboprophylaxis</title>
            <link>http://www.medworm.com/index.php?rid=2633238&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83621%2FThrombosis%2FLMWH_effective_for_pregnancy_mechanical_heart_valve_thromboprophylaxis_.html</link>
            <description>Low molecular weight heparin may offer effective thromboprophylaxis for pregnant women with mechanical heart valves, researchers suggest, by balancing the risks for maternal thrombosis and fetal harm. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2633238</comments>
            <pubDate>Fri, 24 Jul 2009 11:53:26 +0100</pubDate>
            <guid isPermaLink="false">2633238</guid>        </item>
        <item>
            <title>DVT found in quarter of superficial vein thrombosis patients</title>
            <link>http://www.medworm.com/index.php?rid=2624723&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83591%2FThrombosis%2FDVT_found_in_quarter_of_superficial_vein_thrombosis_patients.html</link>
            <description>Patients with superficial vein thrombosis are at risk for deep vein thrombosis, say researchers who found that up to one in four patients developed the more serious thromobotic condition. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2624723</comments>
            <pubDate>Wed, 22 Jul 2009 11:53:42 +0100</pubDate>
            <guid isPermaLink="false">2624723</guid>        </item>
        <item>
            <title>CTEPH ‘not uncommon’ after PE</title>
            <link>http://www.medworm.com/index.php?rid=2616408&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83553%2FThrombosis%2FCTEPH_%E2%80%98not_uncommon%E2%80%99_after_PE.html</link>
            <description>Up to 10% of patients with a first episode of pulmonary embolism may develop asymptomatic or symptomatic chronic thromboembolic pulmonary hypertension, study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2616408</comments>
            <pubDate>Mon, 20 Jul 2009 11:48:39 +0100</pubDate>
            <guid isPermaLink="false">2616408</guid>        </item>
        <item>
            <title>Thromboembolic care ‘priority’ for thrombocytopenia patients</title>
            <link>http://www.medworm.com/index.php?rid=2613073&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83541%2FThrombosis%2FThromboembolic_care_%E2%80%98priority%E2%80%99_for_thrombocytopenia_patients.html</link>
            <description>Care for patients with heparin-related thrombocytopenia should focus on preventing and treating thromboembolic events , US researchers recommend in the American Journal of Cardiology. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2613073</comments>
            <pubDate>Sat, 18 Jul 2009 11:22:19 +0100</pubDate>
            <guid isPermaLink="false">2613073</guid>        </item>
        <item>
            <title>Optimal INR suggested for OAT indications</title>
            <link>http://www.medworm.com/index.php?rid=2609876&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83521%2FThrombosis%2FOptimal_INR_suggested_for_OAT_indications.html</link>
            <description>The optimal intensity of oral anticoagulant therapy varies with indication, say researchers after calculating international normalized ratio-specific incidence rates for bleeding and thrombosis among different patient populations. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2609876</comments>
            <pubDate>Fri, 17 Jul 2009 11:49:44 +0100</pubDate>
            <guid isPermaLink="false">2609876</guid>        </item>
        <item>
            <title>sTM identifies warfarin users at bleeding risk</title>
            <link>http://www.medworm.com/index.php?rid=2600452&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83492%2FThrombosis%2FsTM_identifies_warfarin_users_at_bleeding_risk.html</link>
            <description>Measuring thrombomodulin levels during warfarin treatment may help identify patients at increased risk for bleeding, suggests research published in the Archives of Internal Medicine. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2600452</comments>
            <pubDate>Wed, 15 Jul 2009 11:46:18 +0100</pubDate>
            <guid isPermaLink="false">2600452</guid>        </item>
        <item>
            <title>Negative complete compression ultrasound rules out DVT</title>
            <link>http://www.medworm.com/index.php?rid=2597211&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83478%2FThrombosis%2FNegative_complete_compression_ultrasound_rules_out_DVT.html</link>
            <description>A single negative complete compression ultrasound in an ambulatory office setting provides sufficient evidence to rule out deep vein thrombosis, say French researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2597211</comments>
            <pubDate>Tue, 14 Jul 2009 11:50:06 +0100</pubDate>
            <guid isPermaLink="false">2597211</guid>        </item>
        <item>
            <title>tPA gene therapy may reduce early vein graft thrombosis</title>
            <link>http://www.medworm.com/index.php?rid=2590467&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83437%2FThrombosis%2FtPA_gene_therapy_may_reduce_early_vein_graft_thrombosis.html</link>
            <description>Gene therapy with human tissue plasminogen activator, results in fewer, less severe cyclic flow reductions and better blood flow after saphenous vein graft in pigs, say researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2590467</comments>
            <pubDate>Sat, 11 Jul 2009 11:45:10 +0100</pubDate>
            <guid isPermaLink="false">2590467</guid>        </item>
        <item>
            <title>Monoclonal antibody fragments block in vitro TAFI activation</title>
            <link>http://www.medworm.com/index.php?rid=2587182&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83420%2FThrombosis%2FMonoclonal_antibody_fragments_block_in_vitro_TAFI_activation.html</link>
            <description>Antibody fragments derived from monoclonal antibodies against human thrombin activatable fibrinolysis inhibitor are capable of blocking TAFI activation and reducing clot lysis time in vitro, study results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2587182</comments>
            <pubDate>Fri, 10 Jul 2009 11:54:14 +0100</pubDate>
            <guid isPermaLink="false">2587182</guid>        </item>
        <item>
            <title>Travel linked to three-fold higher risk for VTE</title>
            <link>http://www.medworm.com/index.php?rid=2579188&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83376%2FThrombosis%2FTravel_linked_to_three-fold_higher_risk_for_VTE.html</link>
            <description>Travel by any mode of transportation is associated with a nearly three-fold increased risk for venous thromboembolism, compared with non-travelers, results of a meta-analysis have shown. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2579188</comments>
            <pubDate>Wed, 08 Jul 2009 11:55:20 +0100</pubDate>
            <guid isPermaLink="false">2579188</guid>        </item>
        <item>
            <title>Autoimmune reaction causes false positive HIT results in APS</title>
            <link>http://www.medworm.com/index.php?rid=2575450&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F83355%2FThrombosis%2FAutoimmune_reaction_causes_false_positive_HIT_results_in_APS.html</link>
            <description>A large proportion of patients with antiphospholipid syndrome and/or systemic lupus erythematosus have false-positive heparin-induced thrombocytopenia test results, say researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2575450</comments>
            <pubDate>Tue, 07 Jul 2009 11:47:41 +0100</pubDate>
            <guid isPermaLink="false">2575450</guid>        </item>
    </channel>
</rss>
